VULM 1457
VULM 1457 is a potent ACAT inhibitor with significant hypolipidemic activity. It improves outcomes in myocardial ischemia-reperfusion injury models and has been shown in vitro to reduce adrenomedullin production and receptor expression in human hepatoblastic cells, supporting research in cardiovascular and metabolic diseases.
Product Specifications
CAS Number
228544-65-8
Product Name Alternative
VULM 1457, VULM1457, VULM-1457, diabetes mellitus, Diacylglycerol acyltransferase, Diglyceride acyltransferase, cholesterol acyltransferase, ACAT, Acyltransferase, acyl-CoA:cholesterol acyltransferase, acyl-CoA, Inhibitor, mono- acylglycerol acyltransferase, hypolipidaemic, hypercholesterolaemia, myocardial, ischaemia-reperfusion, inhibit
Field of Research
Metabolism Research
Purity
99.73% (May vary between batches)
Solubility
DMSO:60 mg/mL (133.46 mM)
Smiles
CC (C) c1cccc (C (C) C) c1NC (=O) Nc1ccc (Sc2ccc (cc2) [N+] ([O-]) =O) cc1
Molecular Formula
C25H27N3O3S
Molecular Weight
449.57
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Lsx09029-50gEcoli 50 µg (E. coli)
Recombinant Shigella Boydii apt Protein (aa 1-183) (strain CDC 3083-94 / BS512)
Sign In for Pricing
View Details 
LV715579 1.0 µg DNA
SUMF2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details 
K4315207 1.0 µg DNA
Gm12185 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)
Sign In for Pricing
View Details